Opposite effects of two estrogen receptors on tau phosphorylation through disparate effects on the miR‐218/PTPA pathway

• Published in: Aging cell 2015-10, Vol.14 (5), p.867-877
• Main Authors: Xiong, Yan‐Si, Liu, Fang‐Fang, Liu, Dan, Huang, He‐Zhou, Wei, Na, Tan, Lu, Chen, Jian‐Guo, Man, Heng‐Ye, Gong, Cheng‐Xin, Lu, Youming, Wang, Jian‐Zhi, Zhu, Ling‐Qiang
• Format: Article
• Language: English
• Subjects: Advertising executives; Alzheimer Disease - enzymology; Alzheimer Disease - metabolism; Alzheimer's disease; Animals; Cells, Cultured; Estrogen; estrogen receptor; Estrogen Receptor alpha - genetics; Estrogen Receptor alpha - metabolism; Estrogen Receptor beta - genetics; Estrogen Receptor beta - metabolism; Estrogens; Glycogen; HEK293 Cells; Humans; Kinases; Male; Mice; Mice, Transgenic; MicroRNAs - genetics; MicroRNAs - metabolism; miR‐218; Original; Pathogenesis; Phenols; Phosphatase; Phosphatases; Phosphorylation; Proteins; PTPα; Receptor-Like Protein Tyrosine Phosphatases, Class 4 - genetics; Receptor-Like Protein Tyrosine Phosphatases, Class 4 - metabolism; Synthesis; Target marketing; tau Proteins - chemistry; tau Proteins - metabolism; tauopathy; Tyrosine
• ISSN: 1474-9718; 1474-9726
• DOI: 10.1111/acel.12366

Summary The two estrogen receptors (ERs), ERα and ERβ, mediate the diverse biological functions of estradiol. Opposite effects of ERα and ERβ have been found in estrogen‐induced cancer cell proliferation and differentiation as well as in memory‐related tasks. However, whether these opposite effects are implicated in the pathogenesis of Alzheimer's disease (AD) remains unclear. Here, we find that ERα and ERβ play contrasting roles in regulating tau phosphorylation, which is a pathological hallmark of AD. ERα increases the expression of miR‐218 to suppress the protein levels of its specific target, protein tyrosine phosphatase α (PTPα). The downregulation of PTPα results in the abnormal tyrosine hyperphosphorylation of glycogen synthase kinase‐3β (resulting in activation) and protein phosphatase 2A (resulting in inactivation), the major tau kinase and phosphatase. Suppressing the increased expression of miR‐218 inhibits the ERα‐induced tau hyperphosphorylation as well as the PTPα decline. In contrast, ERβ inhibits tau phosphorylation by limiting miR‐218 levels and restoring the miR‐218 levels antagonized the attenuation of tau phosphorylation by ERβ. These data reveal for the first time opposing roles for ERα and ERβ in AD pathogenesis and suggest potential therapeutic targets for AD.